Ironshore Pharmaceuticals is a biopharmaceutical company whose mission is to develop and commercialize innovative, patient-centric treatment options to improve the lives of patients and caregivers. The Commercial arm of Ironshore is based in Philadelphia, PA. Ironshore Pharmaceuticals and Development Inc., based in Grand Cayman, directs all Research and Development activities for the company. Both Ironshore Pharmaceuticals and Ironshore Pharmaceuticals and Development, Inc. are wholly owned subsidiaries of Toronto based Highland Therapeutics, Inc. Ironshore has submitted its first New Drug Application (NDA) for a product indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The product leverages Ironshore’s innovative DELEXIS® drug delivery system.
Copyright 2017, a2z, Inc. All rights reserved.